Mr Jeffrey S Mcnish, MA in Epsom, NH - Psychologist

Mr Jeffrey S Mcnish, MA is a Psychologist - School based in Epsom, New Hampshire. Mr Jeffrey S Mcnish is licensed to practice in New Hampshire (license number 42714) and his current practice location is 282 Black Hall Rd, Epsom, New Hampshire. He can be reached at his office (for appointments etc.) via phone at (603) 736-9331.

NPI number for Mr Jeffrey S Mcnish is 1073103982 and his current mailing address is 282 Black Hall Rd, Epsom, New Hampshire. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1073103982.

Contact Information

	Mr Jeffrey S Mcnish, MA
	282 Black Hall Rd, Epsom, NH 03234-4346
	(603) 736-9331
	Not Available

Healthcare Provider's Profile

Full Name	Mr Jeffrey S Mcnish
Gender	Male
Speciality	Psychologist - School
Location	282 Black Hall Rd, Epsom, New Hampshire
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1073103982
Provider Enumeration Date: 01/25/2021
Last Update Date: 01/25/2021

Medical Identifiers

Medical identifiers for Mr Jeffrey S Mcnish such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1073103982	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
103TS0200X	Psychologist - School	42714 (New Hampshire)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Jeffrey S Mcnish is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Jeffrey S Mcnish, MA 282 Black Hall Rd, Epsom, NH 03234-4346 Ph: () -	Mr Jeffrey S Mcnish, MA 282 Black Hall Rd, Epsom, NH 03234-4346 Ph: (603) 736-9331

News Archive

Scientists discover new candidate gene for Dravet syndrome

Dravet syndrome is a severe genetic epilepsy that appears early in life. About 75 percent of cases can be attributed to mutations in the SCN1A gene encoding the sodium channel NaV1.1. The remaining patients with this syndrome are without a definitive molecular genetic diagnosis. Research presented today at the American Epilepsy Society's 65th Annual Meeting has found a non-SCN1A candidate gene and suggests that Dravet syndrome may be caused by any one of a number of yet unidentified genes.

Scripps Research team receives $12 million grant to improve flu and malaria vaccines

Scientists at The Scripps Research Institute aim to improve flu and malaria vaccines with the support of a new $12 million grant from the Bill & Melinda Gates Foundation.

Research findings may lead to treatments for disorders triggered by circadian clock dysfunction

Overnight flights across the Atlantic, graveyard shifts, stress-induced insomnia are all prime culprits in keeping us from getting a good night's sleep. Thanks to new research from McGill University and Concordia University, however, these common sleep disturbances may one day be put to bed.

Resveratrol and quercetin may improve efficacy of existing chemotherapeutic cancer drug

Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential use of an existing chemotherapeutic cancer drug.

YM Biosciences reports on early trials of nimotuzumab in brain metastases and high-grade glioma

YM BioSciences Inc. has announced data from two clinical trials of nimotuzumab, its humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR). Preliminary results from the two trials which are evaluating nimotuzumab in combination with radiation therapy for the treatment of brain metastases and high-grade gliomas, conducted by YM's licensor, were presented at the 2008 EORTC-NCI-AACR annual meeting recently held in Geneva, Switzerland.

Mr Jeffrey S Mcnish, MA - Psychologist in Epsom, NH